Business / Finance

RSS

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

Knopp Biosciences LLC today announced a second collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to investigate the eosinophil-lowering effects of the investigational drug dexpramipexole.

13 Mar 2014

Quad-C Management makes five investments in the last 15 months

Quad-C Management, a leading middle market private equity firm, today announced the firm has made five investments in the last 15 months, including four new investments and one add-on investment to a current portfolio company.

13 Mar 2014

CRO services division of Galapagos to be acquired by Charles River Laboratories

Charles River Laboratories International, Inc. announced today that it has entered into a definitive agreement to acquire the CRO services division of Galapagos NV (Euronext: GLPG), which includes both Argenta and BioFocus.

13 Mar 2014

Galmed Pharmaceuticals prices initial public offering of 2,837,400 shares

Galmed Pharmaceuticals Ltd. ("Galmed") today announced the pricing of its initial public offering of 2,837,400 ordinary shares at a public offering price of $13.50 per share, before underwriting discounts and commissions.

13 Mar 2014

Quintiles prices secondary public offering of 15M shares of common stock

Quintiles today announced the pricing of a secondary public offering of 15 million shares of its common stock by certain of its shareholders at a price to the public of $52.00 per share.

13 Mar 2014

RTI Surgical launches 2 new biological solutions at AAOS annual meeting in New Orleans

RTI Surgical Inc., a leading global surgical implant company, is launching two new biological solutions at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans this week. NanOss Bioactive 3D, a synthetic three dimensional bioscaffold which supports bone formation, and map3™ Cellular Allogeneic Bone Graft, an implant that contains the three essential elements needed to generate and maintain new bone, will be introduced at the RTI Surgical exhibit at booth 5937 (Hall H) during the AAOS meeting.

12 Mar 2014

Respicardia receives Best Innovation of 2014 award from CRT and CV Pipeline for remedē System

Respicardia, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the Best Innovation of 2014 from Cardiovascular Research Technologies (CRT) and CV Pipeline for the remedē System, the first and only implantable device for the treatment of central sleep apnea.

12 Mar 2014

iCAD prices underwritten public offering of 2,400,000 shares of common stock

iCAD, Inc. ("iCAD"), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy solutions for the early identification and treatment of cancer, today announced it has priced a registered firm commitment underwritten public offering of 2,400,000 shares of its common stock at a price to public of $11.00 per share.

12 Mar 2014

Amedisys' net service revenue decreases 13.7% to $303.5 million in Q4 2013

Amedisys, Inc., a leading home health and hospice company, today reported its financial results for the fourth quarter and year ended December 31, 2013.

12 Mar 2014

Precision and Agrivida enter into trait development collaboration based on precise gene modifications

Precision BioSciences and Agrivida revealed today that they have entered into a trait development collaboration based on precise gene modifications made possible by Precision's Directed Nuclease Editor (DNE) Technology.

12 Mar 2014

Novalon Games signs LOI to license new biofeedback technology for mobile gaming applications

Novalon Games, a wholly owned subsidiary of OBJ Enterprises, announced today that it has signed a letter of intent (LOI) to partner with a cutting-edge game developer and potentially license innovative biofeedback technology for use in its growing suite of mobile gaming applications.

12 Mar 2014

Orexo signs multi-year agreement with OptumRx and UnitedHealth Group

Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.

12 Mar 2014

MUSC, Alliance Oncology announce strategic radiation therapy affiliation

The Medical University of South Carolina (MUSC), one of the nation's top academic health science centers, and Alliance Oncology, a division of Alliance HealthCare Services, Inc., announce a newly formed affiliation designed to strengthen and expand MUSC's Hollings Cancer Center as the radiation therapy market leader in Charleston, South Carolina.

12 Mar 2014

MEDIAN Technologies inks €700K deal with leading pharmaceutical company

MEDIAN Technologies, a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, today announced it has signed a contract with a global top five pharmaceutical company.

12 Mar 2014

Nestlé, Biogaia sign new supplementary agreement

In February 2012 BioGaia sold the rights for the use of Lactobacillus reuteri Protectis in infant formula to Nestle for the remainder of the patent lifetime

12 Mar 2014

Washington Trust offers $8.8M to two medical centers located in Providence, RI

Washington Trust's Commercial Real Estate Group recently provided $8.8 million in financing for the refinancing of University Medical Center, LLC located at 195 Collyer St. in Providence, R.I. and Collyer Rehabilitation Center, LLC located at 208 Collyer St.

12 Mar 2014

WiserTogether, Truven Health Analytics team up to help consumers make better healthcare decisions

WiserTogether, Inc., a cloud-based, consumer-focused, health decision-making platform, today announced it has entered into a partnership with Truven Health Analytics, a leading provider of healthcare data and analytics solutions and services. The partnership enables Truven Health Analytics and WiserTogether to provide employers and healthcare plans with a unique set of solutions to help their consumers make better healthcare decisions.

11 Mar 2014

Sysmex America, Henry Schein sign three-year distribution agreement

Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, and Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today announced the signing of a three-year distribution agreement between the companies effective immediately.

From Sysmex America, Inc. 11 Mar 2014

Clinipace Worldwide closes merger with Choice Pharma

Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice Pharma, a Pan-Asian contract research organization. Bringing these organizations together strengthens Clinipace Worldwide's operational and therapeutic expertise in Asia, a region in high demand by Clinipace's clients.

11 Mar 2014